Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

PHASE2CompletedINTERVENTIONAL

Enrollment

375

Participants

Timeline

Start Date

September 30, 1995

Conditions

Leishmaniasis

Interventions

DRUG

allopurinol

DRUG

glucantime

All Listed Sponsors

collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00004755 - Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil | Biotech Hunter | Biotech Hunter